125 related articles for article (PubMed ID: 34128728)
1. Gadolinium Retention in Human Brain, Bone, and Skin.
Tweedle MF
Radiology; 2021 Sep; 300(3):570-571. PubMed ID: 34128728
[No Abstract] [Full Text] [Related]
2. The Issue of Gadolinium Retained in Tissues: Insights on the Role of Metal Complex Stability by Comparing Metal Uptake in Murine Tissues Upon the Concomitant Administration of Lanthanum- and Gadolinium-Diethylentriamminopentaacetate.
Di Gregorio E; Ferrauto G; Furlan C; Lanzardo S; Nuzzi R; Gianolio E; Aime S
Invest Radiol; 2018 Mar; 53(3):167-172. PubMed ID: 28990973
[TBL] [Abstract][Full Text] [Related]
3. Analysis of retention of gadolinium by brain, bone, and blood following linear gadolinium-based contrast agent administration in rats with experimental sepsis.
Damme NM; Fernandez DP; Wang LM; Wu Q; Kirk RA; Towner RA; McNally JS; Hoffman JM; Morton KA
Magn Reson Med; 2020 Jun; 83(6):1930-1939. PubMed ID: 31677194
[TBL] [Abstract][Full Text] [Related]
4. Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents.
Erdene K; Nakajima T; Kameo S; Khairinisa MA; Lamid-Ochir O; Tumenjargal A; Koibuchi N; Koyama H; Tsushima Y
Jpn J Radiol; 2017 Oct; 35(10):568-573. PubMed ID: 28730467
[TBL] [Abstract][Full Text] [Related]
5. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis.
Forslin Y; Martola J; Bergendal Å; Fredrikson S; Wiberg MK; Granberg T
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1265-1273. PubMed ID: 31248867
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
Kiviniemi A; Gardberg M; Ek P; Frantzén J; Bobacka J; Minn H
Neuroradiology; 2019 May; 61(5):535-544. PubMed ID: 30710184
[TBL] [Abstract][Full Text] [Related]
8. A Review of the Current Evidence on Gadolinium Deposition in the Brain.
Pullicino R; Radon M; Biswas S; Bhojak M; Das K
Clin Neuroradiol; 2018 Jun; 28(2):159-169. PubMed ID: 29523896
[TBL] [Abstract][Full Text] [Related]
9. Twitter and Gadolinium Retention: Patient-Reported Perceptions of Gadolinium-Based Contrast Agents.
Huneault L; Davenport MS; Verma R; Walker D; Schieda N
J Am Coll Radiol; 2020 Oct; 17(10):1355-1358. PubMed ID: 32822645
[No Abstract] [Full Text] [Related]
10. Gd-DTPA: an alternative contrast medium for CT.
Quinn AD; O'Hare NJ; Wallis FJ; Wilson GF
J Comput Assist Tomogr; 1994; 18(4):634-6. PubMed ID: 8040451
[TBL] [Abstract][Full Text] [Related]
11. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.
Valk J; de Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI; Nauta JJ
Acta Radiol; 1987; 28(6):659-65. PubMed ID: 2962597
[TBL] [Abstract][Full Text] [Related]
12. Influence of Artifact Corrections on MRI Signal Intensity Ratios for Assessment of Gadolinium Brain Retention.
Saake M; Hepp T; Schmidle A; Wuest W; Heiss R; Doerfler A; Uder M; Bäuerle T
Acad Radiol; 2020 May; 27(5):744-749. PubMed ID: 31466889
[TBL] [Abstract][Full Text] [Related]
13. Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.
Quattrocchi CC; Ramalho J; van der Molen AJ; Rovira À; Radbruch A;
Eur Radiol; 2019 Aug; 29(8):3959-3967. PubMed ID: 30413951
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium Deposition in the Brain: Current Updates.
Choi JW; Moon WJ
Korean J Radiol; 2019 Jan; 20(1):134-147. PubMed ID: 30627029
[TBL] [Abstract][Full Text] [Related]
15. Increased Retention of Gadolinium in the Inflamed Brain After Repeated Administration of Gadopentetate Dimeglumine: A Proof-of-Concept Study in Mice Combining ICP-MS and Micro- and Nano-SR-XRF.
Wang S; Hesse B; Roman M; Stier D; Castillo-Michel H; Cotte M; Suuronen JP; Lagrange A; Radbruch H; Paul F; Taupitz M; Schellenberger E; Sack I; Infante-Duarte C
Invest Radiol; 2019 Oct; 54(10):617-626. PubMed ID: 31033673
[TBL] [Abstract][Full Text] [Related]
16. Retention of gadolinium in the brains of healthy dogs after a single intravenous administration of gadodiamide.
Gambino JM; James JR; Buchweitz JP; Cooley AJ; Lawrence AM; Wills RW; Lee AM
Am J Vet Res; 2018 Sep; 79(9):949-960. PubMed ID: 30153053
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy.
Gibby WA; Gibby KA; Gibby WA
Invest Radiol; 2004 Mar; 39(3):138-42. PubMed ID: 15076005
[TBL] [Abstract][Full Text] [Related]
18. The Critical Need for Pediatric and Juvenile Animal Research Addressing Gadolinium Retention in the Developing Body.
Roberts DR; Chatterjee AR
Invest Radiol; 2019 Feb; 54(2):72-75. PubMed ID: 30273280
[No Abstract] [Full Text] [Related]
19. Distribution and chemical forms of gadolinium in the brain: a review.
Kanda T; Nakai Y; Hagiwara A; Oba H; Toyoda K; Furui S
Br J Radiol; 2017 Nov; 90(1079):20170115. PubMed ID: 28749164
[TBL] [Abstract][Full Text] [Related]
20. Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.
Topcuoglu ED; Topcuoglu OM; Semiz Oysu A; Bukte Y
J Magn Reson Imaging; 2020 May; 51(5):1471-1477. PubMed ID: 31665554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
